IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | ![](/images/2038/7971_B_7_2_rna_selected_60x60.jpg) | Mixed |
SSR1 | Signal sequence receptor, alpha | Predicted membrane proteins
| | | | ![](/images/11276/28384_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | ![](/images/326/770_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | ![](/images/22992/50336_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | ![](/images/29715/61993_A_3_8_rna_selected_60x60.jpg) | Expressed in all |
LRRC16A | Leucine rich repeat containing 16A | | | | | ![](/images/29038/67532_B_8_1_rna_selected_60x60.jpg) | Mixed |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | ![](/images/34012/64695_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
VARS | Valyl-tRNA synthetase | Enzymes Plasma proteins
| | | | ![](/images/46710/107227_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | ![](/images/50550/118261_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | ![](/images/2224/5834_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/31092/66771_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
KLHDC3 | Kelch domain containing 3 | | | | | ![](/images/30131/63785_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
SRF | Serum response factor (c-fos serum response element-binding transcription factor) | Transcription factors
| | | | ![](/images/5416/16240_A_7_7_rna_selected_60x60.jpg) | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Transcription factors
| | | | ![](/images/5941/17334_A_8_8_rna_selected_60x60.jpg) | Mixed |
RUNX2 | Runt-related transcription factor 2 | Disease related genes Transcription factors
| | | | ![](/images/62561/139020_A_5_4_rna_selected_60x60.jpg) | Mixed |
CD2AP | CD2-associated protein | Disease related genes
| | | | ![](/images/3267/10184_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/2162/5732_B_3_7_rna_selected_60x60.jpg) | Expressed in all |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/36359/84389_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | ![](/images/19918/47053_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
MYO6 | Myosin VI | Disease related genes Plasma proteins
| | | | ![](/images/10762/26995_B_8_1_rna_selected_60x60.jpg) | Mixed |
HMGN3 | High mobility group nucleosomal binding domain 3 | | | | | ![](/images/18370/41691_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
PGM3 | Phosphoglucomutase 3 | Enzymes
| | | | ![](/images/29760/64525_A_2_5_rna_selected_60x60.jpg) | Expressed in all |
SYNCRIP | Synaptotagmin binding, cytoplasmic RNA interacting protein | Plasma proteins
| | | | ![](/images/10895/134992_B_8_8_rna_selected_60x60.jpg) | Expressed in all |
MANEA | Mannosidase, endo-alpha | Enzymes Predicted membrane proteins
| | | | ![](/images/11046/27314_B_8_5_rna_selected_60x60.jpg) | Mixed |
UFL1 | UFM1-specific ligase 1 | | | | | ![](/images/30559/67626_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | ![](/images/23887/51855_A_2_6_rna_selected_60x60.jpg) | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/5054/17524_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
EPB41L2 | Erythrocyte membrane protein band 4.1-like 2 | Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/5730/21228_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | ![](/images/27770/57596_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MAP7 | Microtubule-associated protein 7 | | | | | ![](/images/29713/66639_B_7_1_rna_selected_60x60.jpg) | Mixed |
AKAP12 | A kinase (PRKA) anchor protein 12 | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/6344/17765_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/21616/50441_A_9_1_rna_selected_60x60.jpg) | Expressed in all |
WTAP | Wilms tumor 1 associated protein | | | | | ![](/images/10550/26595_A_2_7_rna_selected_60x60.jpg) | Expressed in all |
PSMB1 | Proteasome (prosome, macropain) subunit, beta type, 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/29635/64707_B_9_3_rna_selected_60x60.jpg) | Expressed in all |